Concepedia

Gary Chrebet

GC

20

Publications

1.9K

Citations

20

H-Index

1989

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Gary Chrebet is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, biochemistry, and pharmacology.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoverySignal TransductionNatural SciencesCell SignalingGene ExpressionMolecular BiologyImmunology

Publications per year

1989–2006

20

Publications

20

A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase

John W. Wallis, Gary Chrebet, Gary Brodsky et al. · Cell · 1989 · 525 citations

Chromatin, Genome Instability, Novel Eukaryotic Topoisomerase +9

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

S. Park, Rosemarie Kelly, Jennifer Nielsen Kahn et al. · Antimicrobial Agents and Chemotherapy · 2005 · 426 citations · Full text

Diagnostic Mycology, Microbial Pathogens, Rare Laboratory +22

Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from α-factor arrest in yeast

Forrest Poor, Stephen A. Parent, Nancy R. Morin et al. · Nature · 1992 · 194 citations

Molecular Pharmacology, Protein Function, Signal Transduction +11

Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P<sub>1</sub>) Receptor Agonists with Exceptional Selectivity against S1P<sub>2</sub> and S1P<sub>3</sub>

Zhen Li, Weirong Chen, Jeffrey J. Hale et al. · Journal of Medicinal Chemistry · 2005 · 99 citations · Full text

Drug Target, Immunology, Pharmacotherapy +17

A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists

Jeffrey J. Hale, Christopher L. Lynch, William Neway et al. · Journal of Medicinal Chemistry · 2004 · 88 citations · Full text

Rows per page

1–5 of 20